Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Priyabrata Chand"'
Autor:
Rajesh Eswarappa, Amit A. Dhudashiya, Kavitha Nellore, DS Samiulla, Sudarshan S. Naremaddepalli, Sasikumar Pottayil, Murali Ramachandra, Archana Bhumireddy, Sandeep Patil, Kiran Aithal, Girish Daginakatte, Gundala Chennakrishna, Wesley Roy Balasubramanian, Priyabrata Chand
Publikováno v:
Cancer Research. 78:3852-3852
Introduction: Most of the immunotherapies currently approved in the clinic target immune checkpoint proteins that suppress T-cell responses. There is growing evidence that the innate immune system also plays an important role in the initiation and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30daaaf99d5f450b2b4ffc6889037e55
https://doi.org/10.1158/1538-7445.am2018-3852
https://doi.org/10.1158/1538-7445.am2018-3852
Autor:
Samiulla D S, S. Pavithra, Chetan Pandit, Kiran Aithal, Murali Ramachandra, Shekar Chelur, Srinivasa Raju Sammeta, Mohan R, Kasieswara Rao, Anirudha Lakshminarasimhan, Sai Sudheer Marri, Sujatha Rajagopalan, Srinivasa Rao Ganipisetty, Dinesh Chikkanna, Naveen Kumar, Sunil Kumar Panigrahi, Thomas Antony, Susanta Samajdar, Narasihmarao K, Darshan Chawla, Girish Daginakatte, Raju Mutyala, Angelene Prasanna, Priyabrata Chand
Publikováno v:
Cancer Research. 78:1392-1392
PRMT5 is a typical type II methyltransferase, transferring two methyl groups to arginine, leading to symmetric dimethylation of the substrate. It can symmetrically methylate histones H2AR3, H3R2, H3R8, and H4R3 and can also methylate many non-histone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::beb02b2d51a9c29b05f94049e2601444
https://doi.org/10.1158/1538-7445.am2018-1392
https://doi.org/10.1158/1538-7445.am2018-1392
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.